Once activated by agents such as IFN-y and bacterial LPS, macrophages (MO)t can inhibit the growth of a wide variety of tumor and microbial targets (1, 2) . Although MO products such as hydrogen peroxide, TNFa, and IL-1 cause cytostasis and/or cytotoxicity (3-5), in many cases these mediators do not appear to be involved . With some targets, Mo-mediated cytostasis and injury to the mitochondria) electron transport chain (METC) require a process associated with MO oxidation of the guanido nitrogens of L-arginine to N02 -/NO3 -(6). However, it is unknown if a metabolite of L-arginine causes these injuries, and if so, which metabolite. Activated Mo have recently been shown to release a compound similar to or identical with the reactive radical nitric oxide (NO .) during metabolism of L-arginine to N02 -/NO3 -(7). This report identifies NO. (or a closely related product) as a mediator of MO-induced cytostasis and mitochondria) respiratory inhibition in lymphoma cells .
Materials and MethodsReagents. Cells were cultured in minimum Eagle's medium, a modification (aMEM) or RPMI 1640 (RPMI ; KC Biological Inc ., Lenexa, KS), both supplemented with 8% bovine calf serum (CS; HyClone Systems, Logan, UT), L-glutamine (584 mg/liter), penicillin (50 U/ml), and streptomycin (50 pg/ml) . Catalase and N°-monomethyl-L-arginine (NMA) were from Calbiochem-Behring Corp. La Jolla, CA. NO . gas (99% pure) and N2 gas (45 ppm 02) were from Matheson Gas Products, East Rutherford, NJ . [Methyl-3 H]TdR (2 Ci/mmol) was from New England Nuclear, Boston, MA. Pure IFN-y was generously provided by Genentech, South San Francisco, CA . LPS (Escherichia coli serotype 0127 : B8) and all other reagents were from Sigma Chemical Co., St . Louis, MO. Concentrated stock solutions were prepared in culture medium (for myoglobin, ascorbate, catalase, NMA, LPS, and IFN-y) or saline (for NaN02, NaN03, FeS04) and sterile filtered (0 .22 pm, Millipore, Danvers, MA) .